Basel Medical Group Ltd
$0.62
▼
-3.08%
2026-04-21 05:43:00
baselmedical.com
NCM: BMGL
Explore Basel Medical Group Ltd stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$10.73 M
Current Price
$0.62
52W High / Low
$9.4 / $0.49
Stock P/E
—
Book Value
$0.23
Dividend Yield
—
ROCE
-25.54%
ROE
-1.64%
Face Value
—
EPS
$-0.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
82
Beta
—
Debt / Equity
120.04
Current Ratio
1.31
Quick Ratio
1.26
Forward P/E
—
Price / Sales
0.97
Enterprise Value
$7.78 M
EV / EBITDA
-3.83
EV / Revenue
0.69
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | DocGo Inc. | $0.68 | — | $64.06 M | — | -59.59% | -89.05% | $2.45 / $0.49 | $1.46 |
| 2. | National HealthCare Corporation | $166.58 | 21.66 | $2.6 B | 1.54% | 10.08% | 11.92% | $177.47 / $89.4 | $68.79 |
| 3. | Pediatrix Medical Group, Inc. | $23.19 | 11.69 | $1.93 B | — | 12.93% | 20.28% | $24.99 / $11.84 | $10.68 |
| 4. | Charming Medical Limited | $29.36 | 441.53 | $497.21 M | — | 396.56% | -232.79% | $31.7 / $4.3 | $0 |
| 5. | Strata Critical Medical, Inc. | $4.52 | 9.61 | $397.54 M | — | -7.31% | -8.01% | $6.02 / $2.51 | $4.18 |
| 6. | The Ensign Group, Inc. | $190 | 32.56 | $11.11 B | 0.13% | 9.31% | 16.89% | $218 / $118.73 | $38.71 |
| 7. | InnovAge Holding Corp. | $7.95 | 172.72 | $1.12 B | — | -4.46% | 1.18% | $10.69 / $2.6 | $1.89 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 11.32 M | 10.05 M | 9.7 M | 10.66 M |
| Operating Profit | -2.18 M | 2.2 M | 2.07 M | 2.47 M |
| Net Profit | -10.64 M | 2.07 M | 1.78 M | 1.98 M |
| EPS in Rs | -0.57 | 0.11 | 0.09 | 0.11 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 18.68 M | 16.31 M | 15.38 M | 16.85 M |
| Total Liabilities | 13.24 M | 8.75 M | 9.89 M | 13.14 M |
| Equity | 5.43 M | 7.56 M | 5.49 M | 3.71 M |
| Current Assets | 13.29 M | 16.17 M | 14.77 M | 15.67 M |
| Current Liabilities | 10.16 M | 7.16 M | 6.47 M | 7.19 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.18 M | 2.51 M | 2.6 M | 2.79 M |
| Investing CF | -8.57 M | -0.01 M | -0.01 M | -0.09 M |
| Financing CF | 12.97 M | -1.77 M | -2.94 M | -12.92 M |
| Free CF | -3.62 M | 2.5 M | 2.59 M | 2.7 M |
| Capex | -0.44 M | -0.01 M | -0.01 M | -0.09 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 12.63% | 3.6% | -8.98% | — |
| Earnings Growth % | -613.11% | 16.23% | -9.84% | — |
| Profit Margin % | -93.96% | 20.62% | 18.38% | 18.56% |
| Operating Margin % | -19.22% | 21.84% | 21.38% | 23.21% |
| Gross Margin % | 77.45% | 77.63% | 75.91% | 79.56% |
| EBITDA Margin % | -85.41% | 30.94% | 30.17% | 30.8% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.